Go Pro

Prenetics Global (PRE) Financials

Prenetics Global logo
$17.85 +1.27 (+7.66%)
Closing price 07/9/2026 04:00 PM Eastern
Extended Trading
$18.01 +0.16 (+0.88%)
As of 07/9/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Prenetics Global

Annual Income Statements for Prenetics Global

This table shows Prenetics Global's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-2.78 -174 -5.99 -64 0.58 0.75
Consolidated Net Income / (Loss)
-1.96 -174 -190 -65 0.58 0.75
Net Income / (Loss) Continuing Operations
-2.78 -219 -5.99 -42 0.58 0.75
Total Pre-Tax Income
-2.78 -217 -5.99 -42 0.58 0.75
Total Operating Income
-2.78 -57 -5.99 -38 -3.20 -3.44
Total Gross Profit
26 3.60 3.62 1.17 0.01 0.01
Total Revenue
0.00 12 0.00 10 0.03 0.07
Operating Revenue
- 13 - 6.16 0.03 0.07
Total Cost of Revenue
0.00 8.93 0.00 4.98 0.02 0.06
Operating Cost of Revenue
- 8.93 - 4.98 0.02 0.06
Total Operating Expenses
2.78 60 5.99 44 3.21 3.45
Other Operating Expenses / (Income)
- 0.29 - 0.00 3.21 3.45
Total Other Income / (Expense), net
0.00 -160 0.00 -3.83 3.78 4.18
Other Income / (Expense), net
- -160 - 3.31 3.78 4.18
Income Tax Expense
- 2.57 - 0.05 0.00 0.00
Weighted Average Basic Shares Outstanding
- - 136.98M 12.21M 12.98M 16.87M
Weighted Average Diluted Shares Outstanding
- - 136.98M 12.21M 12.98M 16.87M
Weighted Average Basic & Diluted Shares Outstanding
- - 136.98M 12.21M 12.98M 16.87M

Quarterly Income Statements for Prenetics Global

No quarterly income statements for Prenetics Global are available.


Annual Cash Flow Statements for Prenetics Global

This table details how cash moves in and out of Prenetics Global's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2.99 -81 175 -201 -66 -85
Net Cash From Operating Activities
-2.88 -99 58 -124 -34 -44
Net Cash From Continuing Operating Activities
-5.83 -99 58 -124 -34 -44
Net Income / (Loss) Continuing Operations
0.00 -174 -190 -65 0.58 0.75
Consolidated Net Income / (Loss)
- -174 -190 -65 0.58 0.75
Amortization Expense
1.13 3.06 1.56 1.92 0.01 0.01
Non-Cash Adjustments To Reconcile Net Income
4.50 64 263 -89 -34 -45
Net Cash From Investing Activities
-5.97 -7.83 -8.32 -80 -0.08 -0.41
Net Cash From Continuing Investing Activities
-5.97 -7.83 -8.32 -80 -0.08 -0.41
Purchase of Property, Plant & Equipment
-3.06 -8.55 -4.95 -0.35 -0.08 -0.42
Sale of Property, Plant & Equipment
0.01 0.71 0.05 0.10 0.00 0.00
Net Cash From Financing Activities
12 26 126 2.69 -32 -40
Net Cash From Continuing Financing Activities
12 26 126 2.69 -32 -40
Repayment of Debt
-0.05 0.00 -42 3.92 -32 -40
Cash Interest Paid
- 0.00 0.17 - 0.02 0.01
Cash Interest Received
- 0.00 0.47 3.94 4.03 3.45

Quarterly Cash Flow Statements for Prenetics Global

No quarterly cash flow statements for Prenetics Global are available.


Annual Balance Sheets for Prenetics Global

This table presents Prenetics Global's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
149 312 254 82 82
Total Current Assets
107 242 94 81 81
Cash & Equivalents
35 147 46 49 7.84
Short-Term Investments
- - - 32 72
Inventories, net
6.83 4.53 3.13 0.05 0.06
Plant, Property, & Equipment, net
13 -243 -210 0.27 0.54
Total Noncurrent Assets
46 94 76 0.38 0.56
Goodwill
3.98 34 29 0.09 0.09
Intangible Assets
24 15 13 0.11 0.10
Other Noncurrent Operating Assets
18 46 33 0.19 0.37
Total Liabilities & Shareholders' Equity
149 312 254 82 82
Total Liabilities
549 69 44 1.73 0.84
Total Current Liabilities
59 57 39 1.67 0.62
Accounts Payable
9.98 7.29 1.67 0.35 0.16
Other Current Liabilities
9.59 5.67 6.11 0.14 0.17
Total Noncurrent Liabilities
92 31 21 0.06 0.22
Capital Lease Obligations
5.27 6.65 2.37 0.06 0.22
Other Noncurrent Operating Liabilities
486 22 16 1.18 0.29
Total Equity & Noncontrolling Interests
-0.08 243 210 80 81
Total Preferred & Common Equity
0.00 237 206 80 80
Preferred Stock
- - - 80 80
Total Common Equity
0.00 237 206 0.00 0.00
Common Stock
0.00 0.01 0.02 0.00 0.00

Quarterly Balance Sheets for Prenetics Global

No quarterly balance sheets for Prenetics Global are available.


Annual Metrics And Ratios for Prenetics Global

This table displays calculated financial ratios and metrics derived from Prenetics Global's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 136,983,110.00 12,205,200.00 12,984,844.00 33,748,178.00
DEI Adjusted Shares Outstanding
0.00 0.00 9,132,207.00 12,205,200.00 12,984,844.00 33,748,178.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.66 -5.25 0.04 0.02
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% -100.00% 0.00% -99.69% 134.26%
EBITDA Growth
0.00% -58,625.22% 100.74% -1,859.65% 102.13% 29.21%
EBIT Growth
0.00% -7,680.37% 97.23% -486.73% 101.64% 29.50%
NOPAT Growth
0.00% -1,947.14% 89.48% -541.91% 88.10% -7.28%
Net Income Growth
0.00% -8,760.85% -9.45% 65.99% 100.89% 29.50%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
0.00% -3,347.46% 158.09% -314.17% 72.72% -30.29%
Free Cash Flow Firm Growth
0.00% 0.00% 1,325.17% -119.84% -571.44% 96.89%
Invested Capital Growth
0.00% 0.00% -411.22% -2.07% 99.38% 156.36%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
0.00% 29.22% 0.00% 11.40% 37.86% 14.48%
EBITDA Margin
0.00% -1,695.89% 0.00% -265.80% 1,849.96% 1,020.36%
Operating Margin
0.00% -461.89% 0.00% -373.68% -10,184.35% -4,663.99%
EBIT Margin
0.00% -1,755.47% 0.00% -341.55% 1,831.53% 1,012.51%
Profit (Net Income) Margin
0.00% -1,411.26% 0.00% -629.64% 1,831.53% 1,012.51%
Tax Burden Percent
70.59% 80.36% 3,180.06% 153.23% 100.00% 100.00%
Interest Burden Percent
100.00% 100.04% 100.00% 120.31% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 208,448.34% -156.51% -28.56% 0.40% 0.93%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -903.91%
Operating Return on Assets (OROA)
0.00% -145.76% 0.00% -12.41% 0.34% 0.91%
Return on Assets (ROA)
0.00% -117.18% 0.00% -22.88% 0.34% 0.91%
Return on Common Equity (ROCE)
0.00% -3,727.91% -152.45% -27.92% 0.28% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -80.34% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.95 -40 -4.19 -27 -3.20 -3.44
NOPAT Margin
0.00% -323.32% 0.00% -261.57% -10,184.35% -4,663.99%
Net Nonoperating Expense Percent (NNEP)
0.00% -893.68% -87.16% -9.90% 1.68% 5.17%
Return On Investment Capital (ROIC_SIMPLE)
- - -1.68% -12.66% -3.98% -4.24%
Cost of Revenue to Revenue
0.00% 72.42% 0.00% 48.43% 62.14% 85.52%
SG&A Expenses to Revenue
0.00% 435.27% 0.00% 283.01% 0.00% 0.00%
R&D to Revenue
0.00% 51.83% 0.00% 89.15% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 489.47% 0.00% 425.25% 10,222.21% 4,678.47%
Earnings before Interest and Taxes (EBIT)
-2.78 -216 -5.99 -35 0.58 0.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.36 -209 1.55 -27 0.58 0.75
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.26 352,189.85 1,022,556.47
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.33 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 5.25 2,251.60 2,776.76
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 122.94 274.25
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.81% 0.36%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 373.80
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.40 2,231.48 2,782.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 120.62 272.73
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 121.84 274.85
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 -63.09 0.03 0.01 0.00 0.00
Long-Term Debt to Equity
0.00 -63.09 0.03 0.01 0.00 0.00
Financial Leverage
0.00 359.62 -1.76 -1.69 -1.54 -1.00
Leverage Ratio
0.00 -1,778.91 1.89 1.25 1.16 1.02
Compound Leverage Factor
0.00 -1,779.69 1.89 1.50 1.16 1.02
Debt to Total Capital
0.00% 101.61% 2.66% 1.11% 0.08% 0.27%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 101.61% 2.66% 1.11% 0.08% 0.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 99.93% 98.85%
Noncontrolling Interests to Total Capital
0.00% -1.64% 2.56% 1.79% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.03% 94.78% 97.10% 0.00% 0.00%
Debt to EBITDA
0.00 -0.03 4.28 -0.09 0.11 0.29
Net Debt to EBITDA
0.00 0.14 -90.10 1.58 -139.20 -106.08
Long-Term Debt to EBITDA
0.00 -0.03 4.28 -0.09 0.11 0.29
Debt to NOPAT
0.00 -0.13 -1.59 -0.09 -0.02 -0.06
Net Debt to NOPAT
0.00 0.75 33.40 1.61 25.29 23.21
Long-Term Debt to NOPAT
0.00 -0.13 -1.59 -0.09 -0.02 -0.06
Altman Z-Score
0.00 0.00 0.00 0.58 25.69 147.61
Noncontrolling Interest Sharing Ratio
0.00% 101.79% 2.59% 2.25% 28.96% 100.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 1.82 4.23 2.37 48.76 129.41
Quick Ratio
0.00 1.40 3.29 1.26 48.53 128.31
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -9.76 120 -24 -159 -4.96
Operating Cash Flow to CapEx
-94.44% -1,267.35% 1,177.48% -50,210.16% -43,176.81% -10,659.49%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.08 0.00 0.04 0.00 0.00
Accounts Receivable Turnover
0.00 0.26 0.00 0.45 0.00 0.00
Inventory Turnover
0.00 1.31 0.00 1.30 0.01 1.15
Fixed Asset Turnover
0.00 0.95 0.00 0.00 0.00 0.18
Accounts Payable Turnover
0.00 0.89 0.00 1.11 0.02 0.25
Days Sales Outstanding (DSO)
0.00 1,392.76 0.00 811.56 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 279.13 0.00 280.64 29,643.88 317.90
Days Payable Outstanding (DPO)
0.00 407.90 0.00 328.30 18,846.23 1,479.92
Cash Conversion Cycle (CCC)
0.00 1,263.99 0.00 763.90 10,797.65 -1,162.03
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 -30 -154 -157 -0.97 0.55
Invested Capital Turnover
0.00 -0.82 0.00 -0.07 0.00 -0.35
Increase / (Decrease) in Invested Capital
0.00 -30 -124 -3.18 156 1.52
Enterprise Value (EV)
0.00 0.00 0.00 14 70 205
Market Capitalization
0.00 0.00 0.00 54 71 205
Book Value per Share
$0.00 $0.00 $1.73 $1.51 $0.00 $0.00
Tangible Book Value per Share
$0.00 $0.00 $1.38 $1.20 ($0.02) ($0.01)
Total Capital
0.00 5.18 250 213 80 81
Total Debt
0.00 5.27 6.65 2.37 0.06 0.22
Total Long-Term Debt
0.00 5.27 6.65 2.37 0.06 0.22
Net Debt
0.00 -30 -140 -43 -81 -80
Capital Expenditures (CapEx)
3.05 7.83 4.90 0.25 0.08 0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 13 38 8.47 -1.29 0.06
Debt-free Net Working Capital (DFNWC)
0.00 48 185 54 80 80
Net Working Capital (NWC)
0.00 48 185 54 80 80
Net Nonoperating Expense (NNE)
0.02 134 186 38 -3.78 -4.18
Net Nonoperating Obligations (NNO)
0.00 -30 -397 -367 -81 -80
Total Depreciation and Amortization (D&A)
2.43 7.35 7.54 7.79 0.01 0.01
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 104.34% 0.00% 82.33% -4,092.05% 83.70%
Debt-free Net Working Capital to Revenue
0.00% 390.53% 0.00% 526.59% 253,633.23% 108,620.29%
Net Working Capital to Revenue
0.00% 390.53% 0.00% 526.59% 253,633.23% 108,620.29%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 9.13M 12.21M 12.98M 16.87M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($5.58) ($3.71) $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 9.13M 12.21M 12.98M 16.87M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 9.13M 12.21M 12.98M 16.87M
Normalized Net Operating Profit after Tax (NOPAT)
-1.95 -40 -4.19 -27 -2.24 -2.40
Normalized NOPAT Margin
0.00% -323.32% 0.00% -261.57% -7,129.05% -3,264.79%
Pre Tax Income Margin
0.00% -1,756.23% 0.00% -410.91% 1,831.53% 1,012.51%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -0.35% -1.90% 0.00% 0.00%

Quarterly Metrics And Ratios for Prenetics Global

No quarterly metrics and ratios for Prenetics Global are available.



Financials Breakdown Chart

Prenetics Global Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Prenetics Global's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Prenetics Global's net income appears to be on a downward trend, with a most recent value of $745.72 thousand in 2025, falling from -$1.96 million in 2020. The previous period was $575.83 thousand in 2024. Find out what analysts predict for Prenetics Global in the coming months.

Prenetics Global's total operating income in 2025 was -$3.44 million, based on the following breakdown:
  • Total Gross Profit: $10.66 thousand
  • Total Operating Expenses: $3.45 million

Over the last 5 years, Prenetics Global's total revenue changed from $0.00 in 2020 to $73.65 thousand in 2025, a change of 7,365,100.0%.

Prenetics Global's total liabilities were at $838.11 thousand at the end of 2025, a 51.7% decrease from 2024, and a 99.8% decrease since 2021.

In the past 4 years, Prenetics Global's cash and equivalents has ranged from $7.84 million in 2025 to $146.66 million in 2022, and is currently $7.84 million as of their latest financial filing in 2025.

Over the last 5 years, Prenetics Global's book value per share changed from 0.00 in 2020 to 0.00 in 2025, a change of 0.0%.



Financial statements for NASDAQ:PRE last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners